Menelaos Pipis,Shawna M E Feely,James M Polke,Mariola Skorupinska,Laura Perez,Rosemary R Shy,Matilde Laura,Jasper M Morrow,Isabella Moroni,Chiara Pisciotta,Franco Taroni,Dragan Vujovic,Thomas E Lloyd,Gyula Acsadi,Sabrina W Yum,Richard A Lewis,Richard S Finkel,David N Herrmann,John W Day,Jun Li,Mario Saporta,Reza Sadjadi,David Walk,Joshua Burns,Francesco Muntoni,Sindhu Ramchandren,Rita Horvath,Nicholas E Johnson,Stephan Züchner,Davide Pareyson,Steven S Scherer,Alexander M Rossor,Michael E Shy,Mary M Reilly,for the Inherited Neuropathies Consortium - Rare Disease Clinical Research Network,Silvia Baratta,Paula Bray,Daniela Calabrese,Kayla Cornett,Gabrielle Donlevy,Katy Eichinger,Maria Foscan,Silvia Genitrini,Natalie Rose Grant,Tara Jones,Diana Lee,Brett A McCray,Stefania Magri,Manoj Menezes,Krista Mullen,Tina Nanji,Sara Nuzzo,Emanuela Pagliano,Roy Poh,Eun Park,Saba Sadaf,Paola Saveri,Carly Siskind,Janet E Sowden,Charlotte J Sumner,Simone Thomas,

Abstract:Abstract Mitofusin-2 (MFN2) is one of two ubiquitously expressed homologous proteins in eukaryote cells, playing a critical role in mitochondrial fusion. Mutations in MFN2 (most commonly autosomal dominant) cause Charcot-Marie-Tooth disease type 2A (CMT2A), the commonest axonal form of CMT, with significant allelic heterogeneity. Previous, moderately-sized, cross sectional genotype-phenotype studies of CMT2A have described the phenotypic spectrum of the disease, but longitudinal natural history studies are lacking. In this large multicentre prospective cohort study of 196 patients with dominant and autosomal recessive CMT2A, we present an in-depth genotype-phenotype study of the baseline characteristics of patients with CMT2A and longitudinal data (1–2 years) to describe the natural history. A childhood onset of autosomal dominant CMT2A is the most predictive marker of significant disease severity and is independent of the disease duration. When compared to adult onset autosomal dominant CMT2A, it is associated with significantly higher rates of use of ankle-foot orthoses, full-time use of wheelchair, dexterity difficulties and also has significantly higher CMT Examination Score (CMTESv2) and CMT Neuropathy Score (CMTNSv2) at initial assessment. Analysis of longitudinal data using the CMTESv2 and its Rasch-weighted counterpart, CMTESv2-R, show that over 1 year, the CMTESv2 increases significantly in autosomal dominant CMT2A (mean change 0.84 ± 2.42; two-tailed paired t-test P = 0.039). Furthermore, over 2 years both the CMTESv2 (mean change 0.97 ± 1.77; two-tailed paired t-test P = 0.003) and the CMTESv2-R (mean change 1.21 ± 2.52; two-tailed paired t-test P = 0.009) increase significantly with respective standardized response means of 0.55 and 0.48. In the paediatric CMT2A population (autosomal dominant and autosomal recessive CMT2A grouped together), the CMT Pediatric Scale increases significantly both over 1 year (mean change 2.24 ± 3.09; two-tailed paired t-test P = 0.009) and over 2 years (mean change 4.00 ± 3.79; two-tailed paired t-test P = 0.031) with respective standardized response means of 0.72 and 1.06. This cross-sectional and longitudinal study of the largest CMT2A cohort reported to date provides guidance for variant interpretation, informs prognosis and also provides natural history data that will guide clinical trial design.

Phenotype variability and histopathological findings in patients with a novel DNM2 mutation.

[A Genotyping Study of 13 Cases of Early-Onset Charcot-Marie-Tooth Disease].

A Novel Mutation of LRSAM1 in a Chinese Family with Charcot-Marie-Tooth Disease

[Progress of Clinical and Genetic Research on Distal Hereditary Motor Neuropathy].

Mitofusin 2 Gene Mutation Causing Early-Onset CMT2A with Different Progressive Courses

New Phenotype of DCTN1‐related Spectrum: Early‐onset Dhmn Plus Congenital Foot Deformity

Clinical and Pathological Features in Charcot-Marie-Tooth Disease Type 2A2: a Family Report

Clinical,pathological and Genetic Studies in a Chinese Charcot-Marie-Tooth Disease Type 2 Family

Mice Carrying an Analogous Heterozygous Dynamin 2 K562E Mutation That Causes Neuropathy in Humans Develop Predominant Characteristics of a Primary Myopathy

The Pathological Features of Common Hereditary Mitochondrial Dynamics Neuropathy

The Genotype and Phenotype Features in a Large Chinese MFN2 Mutation Cohort

Expanding the Phenotypic and Genetic Spectrum of Neuromuscular Diseases Caused by DYNC1H1 Mutations

Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease

Heterogeneous Clinical Phenotypes of Dhmn Caused by Mutation in HSPB1 Gene: A Case Series

A Novel P.val244leu Mutation in MFN2 Leads to Charcot-Marie-Tooth Disease Type 2

A Cohort Study of Han Chinese MFN2-related Charcot–Marie–Tooth 2A

A novel mutation of the MFN2 gene in a Chinese family with Charcot-Marie-Tooth disease.

Natural history of Charcot-Marie-Tooth disease type 2A: a large international multicentre study

MFN2-related genetic and clinical features in a cohort of Chinese CMT2 patients

Analysis of the clinical phenotypes of Charcot -Marie -Tooth disease type 2A2 patients with mitofusin2 mutation

Exome Sequencing Reveals a Novel MFN2 Missense Mutation in a Chinese Family with Charcot-Marie-Tooth Type 2A